Trials / Active Not Recruiting
Active Not RecruitingNCT05331599
Recurrence Markers, Cognitive Burden and Neurobiological Homeostasis in Late-Life Depression
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 210 (estimated)
- Sponsor
- University of Illinois at Chicago · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Accepted
Summary
Late-life depression (LLD) is associated with disability, increased risk for cognitive decline and dementia, elevated suicide risk, and greater all-cause mortality. These outcomes are related to depression being a recurrent disorder, with repeated episodes over a patient's lifetime. Recurrence rates (defined as including both relapse and recurrence) are high in LLD. The goals of this study are to identify neurobiological factors that predict recurrence risk, and examine how cognitive performance changes are both influenced by these neurobiological factors and also predict recurrence risk.
Conditions
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2025-05-15
- Completion
- 2026-01-15
- First posted
- 2022-04-15
- Last updated
- 2025-09-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05331599. Inclusion in this directory is not an endorsement.